Chamow and Associates’ expertise in biopharmaceutical product development expands Alira Health’s lifecycle of healthcare advisory services. FRAMINGHAM, Mass. – January 7, 2021 – Alira Health (www.alirahealth.com), a leading international healthcare…
Chamow & Associates is pleased to announce a new Webinars page on our website. This page is now available under the “Insights” section. Here our visitors will find the following:…
Chamow & Associates hosted a free webinar titled “CDMO Selection for Bispecific Antibody Development: A Case Study Matching Capability to Need” on December 1, 2020. The webinar addressed the CDMO selection…
Selecting a CDMO for bispecific antibody development can be a challenging affair. What is the CDMO selection process and how can a company best match capability to need? Chamow & Associates is…
The COVID pandemic, which is caused by the coronavirus SARS-CoV-2, has stimulated rapid developments in vaccines, anti-viral therapeutics and other treatments. Because people infected with SARS-CoV-2 respond differently, ranging from…
Every year, during the second week of October, the scientific community acknowledges its brightest stars with the announcement of the Nobel Prizes in Stockholm. Two Nobel Prizes were awarded this…
Dr. Steven Chamow is presenting at two virtual conferences this week, the 11th Annual World Bispecific Conference and BioProcess International Conference. Both presentations are available for viewing on the Chamow &…
Chamow & Associates is pleased to present a blog series detailing best practices for working with a contract development and manufacturing organization (CDMO). This series is intended to provide a…
Chamow & Associates is pleased to announce that BioProcess International has nominated our article, “Capture of CH1-Containing Bispecific Antibodies: Evaluating an Alternative to Protein A,” by Steven M. Chamow, Angela…
Chamow & Associates hosted a free webinar titled, "Developing Therapeutic Monoclonal Antibodies at Pandemic Pace" on August 25, 2020. The webinar addressed how the speed of CMC development can be…